These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31013906)

  • 1. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors.
    Zhu S; Zhang C; Huang LS; Zhang XQ; Xu Y; Fang X; Zhou J; Wu M; Schooley RT; Huang Z; An J
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of divalent-metal-induced activation of NS3 helicase and insights into Zika virus inhibitor design.
    Cao X; Li Y; Jin X; Li Y; Guo F; Jin T
    Nucleic Acids Res; 2016 Dec; 44(21):10505-10514. PubMed ID: 27915293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs.
    Ezzemani W; Altawalah H; Windisch M; Ouladlahsen A; Saile R; Kettani A; Ezzikouri S
    J Biomol Struct Dyn; 2024 Sep; 42(15):8073-8088. PubMed ID: 37528667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
    Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
    Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
    Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
    Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
    Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
    J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysulfonate suramin inhibits Zika virus infection.
    Tan CW; Sam IC; Chong WL; Lee VS; Chan YF
    Antiviral Res; 2017 Jul; 143():186-194. PubMed ID: 28457855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies.
    Mishra SS; Kumar N; Karkara BB; Sharma CS; Kalra S
    Mol Divers; 2023 Aug; 27(4):1689-1701. PubMed ID: 36063275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
    Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
    Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
    Akaberi D; Chinthakindi PK; Båhlström A; Palanisamy N; Sandström A; Lundkvist Å; Lennerstrand J
    J Biomol Struct Dyn; 2020 Nov; 38(18):5526-5536. PubMed ID: 31880199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Pipeline for Flavivirus Based Inhibitors for Zika Virus NS1.
    Raza S; Abbas G; Azam SS
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1751-1761. PubMed ID: 30990437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery.
    Kumar D; Aarthy M; Kumar P; Singh SK; Uversky VN; Giri R
    J Biomol Struct Dyn; 2020 Oct; 38(16):4827-4837. PubMed ID: 31690231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening.
    Singh A; Jana NK
    Comput Biol Chem; 2017 Dec; 71():144-151. PubMed ID: 29096380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Bispecific Lead Compounds from
    Kumar S; El-Kafrawy SA; Bharadwaj S; Maitra SS; Alandijany TA; Faizo AA; Khateb AM; Dwivedi VD; Azhar EI
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS; Chu YK; Golden JE; Chung DH
    Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
    Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.